| Literature DB >> 17262717 |
Carrie A Sailer1, Gregory B Pott, Charles A Dinarello, Samantha Ma Whinney, Jeri E Forster, Jacqueline K Larson-Duran, Alan Landay, Lena Al-Harthi, Robert T Schooley, Constance A Benson, Franklyn N Judson, Melanie Thompson, Frank J Palella, Leland Shapiro.
Abstract
Interleukin (IL)-18 generates T helper 1-type immunity and inhibits human immunodeficiency virus type 1 (HIV-1) in primary cells in vitro. Because IL-18 may participate in HIV-1 containment, whole-blood IL-18 levels were measured in 20 healthy control subjects and longitudinally in 28 subjects with early HIV-1 infection. Compared with those in control subjects, IL-18 levels were higher during early HIV-1 infection, and IL-18 levels predicted reduced CXCR4 HIV-1 coreceptor expression and diminished interferon (IFN)- gamma levels. By contrast, a direct association between IL-18 and IFN- gamma levels was observed in blood stimulated with lipopolysaccharide. During early HIV-1 infection, IL-18 may regulate HIV-1 coreceptor expression and have antiretroviral activity.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17262717 DOI: 10.1086/511435
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226